Integra LifeSciences Completes the Sale of its Extremity Orthopedics Business to Smith+Nephew
January 04, 2021 12:49 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has completed its...
Integra LifeSciences to Present at 39th Annual J.P. Morgan Healthcare Conference
December 21, 2020 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Peter Arduini,...
Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.
December 16, 2020 08:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a...
Integra LifeSciences Reports Third Quarter 2020 Financial Results
October 28, 2020 06:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences Announces Preliminary Third Quarter Revenue Results; Will Host Third Quarter 2020 Financial Results Conference Call on October 28, 2020
October 06, 2020 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited...
Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
September 29, 2020 08:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a...
Integra LifeSciences Announces September 2020 Investor Conference Schedule
September 02, 2020 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in...
Integra LifeSciences Reports Second Quarter 2020 Financial Results
August 10, 2020 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences Receives FDA Clearance for Specific Neurosurgery Indication for CUSA® Clarity
July 22, 2020 08:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 22, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, announced today that it has received FDA...
Integra LifeSciences Announces Preliminary Second Quarter Revenue Results; Will Host Second Quarter 2020 Financial Results Conference Call on August 10, 2020
July 09, 2020 16:15 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited...